a total of 33 evaluable patients with multiple myeloma refractory to alkylating agents were treated with the regimen vincristine , bcnu , doxorubicin , and prednisone ( vbap ) at 3-week intervals in a single institution for a 5-yr period .
C0026764
multiple myeloma
C0007257
vbap